Changes in Epidemiology of Candidemia in the United States with a Focus on Candida auris

Clicks: 3
ID: 313934
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #468 of 532 articles by views in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 532 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
BACKGROUND: Candidemia is a common complication in hospitalized and critically ill patients. Nationwide United States (U.S.) data on candidemia risk factors, species, antifungal resistance, and outcomes remain limited. Our objective was to describe candidemia trends from 2015-2024 and identify risk factors for Candida auris candidemia. METHODS: Retrospective study using the Epic Cosmos database. We analyzed trends in candidemia risk factors and outcomes. 30-day mortality was evaluated using multivariable logistic regression adjusted for age, Elixhauser Comorbidity Index, COVID-19-related hospitalization, ICU-acquired candidemia, and calendar year. We compared characteristics of patients with C. auris vs. non-C. auris candidemia. RESULTS: A total of 29,454 candidemia cases were identified among 27,926 unique patients; candidemia incidence increased over time (p=0.02). Overall 30-day mortality was 31.5%, and increased significantly over the study period (from 24.7% to 31.8%; p=0.02). There were similar trends in in-hospital mortality (p=0.01) and intensive care unit-acquired candidemia (p=0.03). The proportion of cases involving C. albicans decreased (p=0.05) while C. auris cases increased (p=0.008). Patients with C. auris candidemia were more likely to be Black, have renal failure, and have a higher Social Vulnerability Index (p<0.001 for all comparisons). Fluconazole resistance increased in C. parapsilosis (from 2.5% to 10.8%, p=0.02) and C. tropicalis (from 6.2% to 18.1%, p=0.03). CONCLUSIONS: Candidemia-associated 30-day mortality increased over the past decade, aligning with a trend toward older, more acutely ill patients developing candidemia. C. auris candidemia was associated with Black race, higher social vulnerability, and renal failure. Overall, our findings highlight concerning nationwide U.S. candidemia trends.
Reference Key
openalex_W7160928253 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors María Alejandra Pérez, Khush Patel, Laila Rasmy, Hisato Yoshida, Cesar A Arias, Masayuki Nigo, Max W Adelman
Journal Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Year 2026
DOI
10.1093/cid/ciag312
URL
https://doi.org/10.1093/cid/ciag312
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.